Corporate expenditure requires a clear JUSTIFICATION with appropriate costing, plans, target statements, projected ups and downs, variations, amortisation ECT .
My understanding is the reply to tender is due MID FEB and AHR would now have the INDEPENDENT draft or the Final Scoping study. (NOTE it could be a negotiation tool not to have the final then it would not have to be released)
One assumes the Chinese are buying on market but as another poster suggested the Chinese are not buying all the stock hopefully we have another buyer. (Refer last major holding announcement.)
Bottom line is I would love to be a fly on the wall as the AHR Directors and Advisors are finalising the reply.
The Chinese are very intelligent negotiators. The art of selling is not having to sell. The art of buying is not having to buy. At least with a formal bid and employing advisers both parties intend to buy and sell. PRICE?
Sit back enjoy the ride one way or another we are on a winner
AHR Price at posting:
27.0¢ Sentiment: Hold Disclosure: Held